PhaseBio Pharmaceuticals Preferred Stock (Total)

Preferred Stock (Total) of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Preferred Stock (Total) growth rates and interactive chart.

Highlights and Quick Summary

  • Preferred Stock (Total) for the quarter ending September 30, 2018 was $126 Million (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly Preferred Stock (Total) increased by Infinity%
  • Annual Preferred Stock (Total) for 2017 was $89.6 Million
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Preferred Stock (Total) of PhaseBio Pharmaceuticals

Most recent Preferred Stock (Total)of PHAS including historical data for past 10 years.

Interactive Chart of Preferred Stock (Total) of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Preferred Stock (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2018 $125.61 $0.0 $0.0
2017 $0.0 $89.63

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology